Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report on the developing market for anti fungal treatments. Anti-Infectives: World Market, 2nd. Ed., Vol. I: Antifungals, forecasts that the market will grow to more than $7 billion within five years.

Fungal infections are now the third most common hospital acquired infection, with more than million people suffering globally. So, with the escalating incidence of fungal conditions worldwide the market prescription and over the counter anti-fungal medications could reach in excess of $7 billion.

The oral and non oral anti-fungal market alone is expected to reach $5.4 billion by 2011. However, product sales in both systemic and topical market segments are facing increased competition from generic medications. New product developments should also help to increase the market.

This report highlights the progress of new types of anti fungal medication and the promising potential of advances in infection imaging. It includes a review of products currently used and in development, in-depth profiles of leading competitors, key issues and trends, and U.S. and world incidence of fungal infections with associated sales forecasts.

Report Buyer product ID: KAL00011